Metraipolis › archive › dc_374460ea2961

DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study — Europe PMC PMID:42292418

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292418
DOI
10.3389/fimmu.2026.1779170
License (as archived)
solo-consultazione
Archived
2026-11-01T05:04:12.034Z
SHA-256 of the archived text
721f67add432d240fce1ddb68b4fbb2e4cb1518154c6d0d1d567c45da02e3c7a
Stable URL of this page
https://metraipolis.com/documento/dc_374460ea2961

How to cite

DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study — Europe PMC PMID:42292418 — Europe PMC (en), https://europepmc.org/article/MED/42292418 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_374460ea2961 (Metraipolis archive dc_374460ea2961, sha256 721f67add432d240fce1ddb68b4fbb2e4cb1518154c6d0d1d567c45da02e3c7a)
BibTeX
@misc{dc374460ea2961,
  title = {DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study — Europe PMC PMID:42292418},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292418},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_374460ea2961; sha256 721f67add432d240fce1ddb68b4fbb2e4cb1518154c6d0d1d567c45da02e3c7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292418. Agents can read the archived copy with the MCP tool read_document.